fda warning letters compounded semaglutide tirzepatide 2024 2025 Troubling Findings in Study of GLP-1 Compounders FDA warns against compounded versions

D., Lange, J

Functionalization of metal nanoclusters for biomedical applications

Despite their clinical uses, these drugs are strongly reinforcing, and their long-term use at high doses is linked with potential addiction, especially when they are rapidly administered or when high-potency forms are given

Mastaitis, J.W., et al., GDF8 and activin A blockade protects against GLP-1-induced muscle loss while enhancing fat loss in obese male mice and non-human primates

Beyond its role as a scavenger, it helps the body recycle other antioxidants, such as Vitamin C and Vitamin E, making them more effective

The favorable profile refers to their exemplary efficacy in addressing hyperglycemia, their safety, low risk of hypoglycemia, their multilevel pathophysiological superiority, weight loss and the reported benefits in CVD reduction